Our results showed that CRO15 directly decreases MELK kinase activity during in vitro kinase assay but also in intact melanoma cells, as indicated by the inhibition of NF-κB phosphorylation and some mitotic makers, such as Cyclin E, CDK1 or CDK2. Here, CDK2 is linked to melanoma.